Short Interest in Green Thumb Industries Inc. (OTCMKTS:GTBIF) Drops By 36.6%

Green Thumb Industries Inc. (OTCMKTS:GTBIF - Get Free Report) was the target of a significant decline in short interest in February. As of February 15th, there was short interest totalling 14,900 shares, a decline of 36.6% from the January 31st total of 23,500 shares. Based on an average daily trading volume, of 1,295,100 shares, the days-to-cover ratio is currently 0.0 days.

Wall Street Analysts Forecast Growth

Separately, Roth Capital upgraded shares of Green Thumb Industries to a "strong-buy" rating in a research report on Sunday, November 10th. Two research analysts have rated the stock with a buy rating and three have issued a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Strong Buy" and an average price target of $16.50.

Green Thumb Industries Trading Up 6.4 %

Shares of Green Thumb Industries stock traded up $0.43 on Wednesday, reaching $7.12. 766,341 shares of the stock were exchanged, compared to its average volume of 498,437. The firm has a market capitalization of $1.51 billion, a PE ratio of 29.67 and a beta of 1.31. Green Thumb Industries has a 1-year low of $6.08 and a 1-year high of $16.33. The business has a fifty day moving average price of $7.30 and a two-hundred day moving average price of $8.88.

Green Thumb Industries (OTCMKTS:GTBIF - Get Free Report) last released its earnings results on Wednesday, February 26th. The company reported $0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.06 by ($0.02). The business had revenue of $294.32 million for the quarter, compared to analyst estimates of $289.66 million. Green Thumb Industries had a return on equity of 3.39% and a net margin of 5.38%. Research analysts expect that Green Thumb Industries will post 0.32 EPS for the current year.

Remove Ads

About Green Thumb Industries

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.